PR Log - Jul 13, 2012 - RayBiotech, a leading developer of high-throughput protein array technologies, recognizes tebu-bio as a CSP in response to their continued demonstration of proficiency in all aspects of array processing and data analysis.  This certification enables tebu-bio to provide full array services directly to researchers in their European territories, eliminating the need for overseas shipping of precious biological specimens.

tebu-bio’s new CSP status not only enhances their existing service portfolio, but allows researchers to easily benefit from the use of antibody-based protein profiling to advance their biomedical research, particularly in the field of disease biomarker discovery.

Commenting on their certification, Nathalie Bervas, Marketing Specialist for tebu-bio, says “RayBiotech’s antibody arrays are an important technology which is in high demand across Europe : on one side profiling antibody arrays allow researchers to identify new targets for their projects, on the other side Quantibody arrays provide multiplex full quantification. We are proud to offer our clients the full testing service option for both types of arrays. With faster turn-around times and direct communication of our array expertise, our customers can fully enjoy the benefits of RayBiotech’s proprietary high-throughput technology.”

Dr. Rob Burgess, Director of Business Development for RayBiotech, remarked, “tebu-bio is a top-performing RayBiotech distributor, showing excellence not only in product sales, but in their level of technical expertise. We are delighted to endorse tebu-bio’s testing facility as an official provider of RayBio antibody array services.”

For further information, visit the tebu-bio website or contact Nathalie Bervas (nathalie.bervas@tebu-bio.com).

About tebu-bio:
tebu-bio is an expert in the supply of the most innovative range of Lab Services & Reagents for Life Sciences throughout Europe. Their headquarters are situated in France, with a pan-European network of offices for local customer service and support.
tebu-bio's lab services are aimed at helping researchers, allowing them to concentrate their efforts on high value activities. tebu-bio Laboratories also offer support through sharing or taking over a project when time or hands are short, as well as enabling researchers to access techniques not yet available in their own laboratories.
Researchers benefit from tebu-bio Laboratories' expertise through outsourcing their recombinant protein production, cell line development & engineering and cell amplification, cloning and plasmid preps, gene and protein profiling, screening compounds and functional bioassays on various biomarkers.

About RayBiotech, Inc.
RayBiotech (www.raybiotech.com) pioneered the development of antibody and protein array technologies and provides reliable high-throughput platforms for identifying disease mechanisms, screening and validation of novel biomarkers and identification of new drug targets.  In 2001, RayBiotech introduced the first commercially available cytokine antibody array. Since then, RayBiotech array products have been featured in hundreds of publications, including some in top-tier journals: Nature, Nature Medicine, Cell, Lancet, PNAS (USA), and many others. Offering more antibody array choices than any of its competitors, RayBiotech has established a leading reputation for the high quality and innovative developments provided to the research community. RayBiotech continues to lead in the development of protein array technologies and is focused on further meeting the needs of clients in translating new knowledge of human biology to improved health. A spin-off from Emory University’s School of Medicine, RayBiotech is privately owned, with headquarters in metropolitan Atlanta (Norcross, GA).

Read Full Story - tebu-bio is now Certified Service Provider for RayBiotech’s portfolio of antibody arrays | More news from this source

Press release distribution by PRLog